Literature DB >> 18520720

Transient receptor potential vanilloid channels in hypertension, inflammation, and end organ damage: an imminent target of therapy for cardiovascular disease?

Donna H Wang1.   

Abstract

PURPOSE OF REVIEW: The possible role of several neurohormonal factors in pathogenesis of hypertension has been studied extensively both in humans and in experimental animal models. However, controversial data from some previous studies are indecisive and call for reassessment and development of new targets. This mini-review presents some of the most recent findings about the role of transient receptor potential vanilloid type 1 channels in the development of hypertension and its pathology. RECENT
FINDINGS: The transient receptor potential vanilloid type 1, channel activated by novel endovanilloids or altered pH, temperature, and/or local hemodynamics, may serve as a distinct molecular sensor detecting sodium and water balance and may play a role in preventing salt-induced hypertension and tissue damage. Impairment of the function of the transient receptor potential vanilloid type 1 channels may contribute to increased salt sensitivity, inflammation, and end organ damage.
SUMMARY: Emerging evidence indicates that the transient receptor potential vanilloid type 1 channel plays a key role in cardiovascular health and disease by acting as a sensor and regulator of cardiovascular homeostasis and a protector against cardiovascular injury. Given the huge population who suffers from cardiovascular disease, the study of the transient receptor potential vanilloid channels may improve our understanding of pathogenesis of several common cardiovascular disorders and may lead to the development of therapy for hypertension, inflammation, and organ damage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18520720      PMCID: PMC2692878          DOI: 10.1097/HCO.0b013e32830460ad

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  127 in total

Review 1.  Anandamide and vanilloid TRPV1 receptors.

Authors:  Ruth A Ross
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

2.  The mammalian amiloride-insensitive non-specific salt taste receptor is a vanilloid receptor-1 variant.

Authors:  Vijay Lyall; Gerard L Heck; Anna K Vinnikova; Shobha Ghosh; Tam-Hao T Phan; Rammy I Alam; Oneal F Russell; Shahbaz A Malik; John W Bigbee; John A DeSimone
Journal:  J Physiol       Date:  2004-05-14       Impact factor: 5.182

3.  Activation of protein kinase C reverses capsaicin-induced calcium-dependent desensitization of TRPV1 ion channels.

Authors:  Sravan Mandadi; Mitsuko Numazaki; Makoto Tominaga; Manjunatha B Bhat; Patricia J Armati; Basil D Roufogalis
Journal:  Cell Calcium       Date:  2004-05       Impact factor: 6.817

4.  Desensitization of capsaicin-activated currents in the vanilloid receptor TRPV1 is decreased by the cyclic AMP-dependent protein kinase pathway.

Authors:  Durga P Mohapatra; Carla Nau
Journal:  J Biol Chem       Date:  2003-09-23       Impact factor: 5.157

5.  Phosphorylation of vanilloid receptor 1 by Ca2+/calmodulin-dependent kinase II regulates its vanilloid binding.

Authors:  Jooyoung Jung; Jae Soo Shin; Soon-Youl Lee; Sun Wook Hwang; Jaeyeon Koo; Hawon Cho; Uhtaek Oh
Journal:  J Biol Chem       Date:  2003-11-20       Impact factor: 5.157

6.  TRPV1 receptors mediate particulate matter-induced apoptosis.

Authors:  N Agopyan; J Head; S Yu; S A Simon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-11-21       Impact factor: 5.464

Review 7.  Endovanilloids. Putative endogenous ligands of transient receptor potential vanilloid 1 channels.

Authors:  Mario Van Der Stelt; Vincenzo Di Marzo
Journal:  Eur J Biochem       Date:  2004-05

8.  Regulated exocytosis contributes to protein kinase C potentiation of vanilloid receptor activity.

Authors:  Cruz Morenilla-Palao; Rosa Planells-Cases; Nuria García-Sanz; Antonio Ferrer-Montiel
Journal:  J Biol Chem       Date:  2004-04-05       Impact factor: 5.157

9.  Protein kinase C phosphorylation sensitizes but does not activate the capsaicin receptor transient receptor potential vanilloid 1 (TRPV1).

Authors:  Gautam Bhave; Hui-Juan Hu; Kathi S Glauner; Weiguo Zhu; Haibin Wang; D J Brasier; Gerry S Oxford; Robert W Gereau
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-01       Impact factor: 11.205

10.  Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures.

Authors:  Sonja Ständer; Corinna Moormann; Mark Schumacher; Jörg Buddenkotte; Metin Artuc; Victoria Shpacovitch; Thomas Brzoska; Undine Lippert; Beate M Henz; Thomas A Luger; Dieter Metze; Martin Steinhoff
Journal:  Exp Dermatol       Date:  2004-03       Impact factor: 3.960

View more
  6 in total

1.  Enhanced salt sensitivity following shRNA silencing of neuronal TRPV1 in rat spinal cord.

Authors:  Shuang-quan Yu; Donna H Wang
Journal:  Acta Pharmacol Sin       Date:  2011-06       Impact factor: 6.150

2.  Inactivation of Bardet-Biedl syndrome genes causes kidney defects.

Authors:  Deng-Fu Guo; Andreas M Beyer; Baoli Yang; Darryl Y Nishimura; Val C Sheffield; Kamal Rahmouni
Journal:  Am J Physiol Renal Physiol       Date:  2010-11-24

3.  Sensing salt intake.

Authors:  Ines Armando; Pedro A Jose
Journal:  Hypertension       Date:  2008-12-15       Impact factor: 10.190

4.  Protective Effects of TRPV1 Activation Against Cardiac Ischemia/ Reperfusion Injury is Blunted by Diet-Induced Obesity.

Authors:  Beihua Zhong; Shuangtao Ma; Donna H Wang
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2020

Review 5.  Does Transient Receptor Potential Vanilloid Type 1 Alleviate or Aggravate Pathological Myocardial Hypertrophy?

Authors:  Qiqi Yan; Jun Tang; Xin Zhang; Liuyang Wu; Yunyi Xu; Lihong Wang
Journal:  Front Pharmacol       Date:  2021-05-10       Impact factor: 5.810

6.  Genetic Variation in Taste Receptor Genes (SCNN1B, TRPV1) and Its Correlation with the Perception of Saltiness in Normotensive and Hypertensive Adults.

Authors:  Pradtana Tapanee; Diane K Tidwell; M Wes Schilling; Daniel G Peterson; Terezie Tolar-Peterson
Journal:  Int J Hypertens       Date:  2021-06-04       Impact factor: 2.420

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.